logo-loader
viewLevi Strauss & Co

Well worn? Levi's shares fall after company reports lower third quarter profits

The company took a hit from its wholesale business throughout the Americas, a key revenue-generating market for the iconic jean maker

Levi Strauss & Co -
The iconic denim brand did beat Wall Street's revenue and earnings expectations

Denim powerhouse Levi Stauss & Co (NYSE:LEVI) saw its overall revenue increase but reported a 4% drop in profits as the manufacturer delivered its fiscal third-quarter results on Tuesday evening. 

The San Francisco-based company took a hit from its wholesale business throughout the Americas, a key revenue-generating market for the iconic brand.

Investors sent Levi’s stock down 2.4% to US$18.93.in premarket trading in New York on Wednesday morning.

READ: Levi Strauss shares pop after swinging to profit in first public quarter since March IPO

During the quarter, the company reported net revenue of US$1.45 billion, a slight increase from the US$1.39 billion during the same period a year prior.

Net income came in at US$124 million or US$0.30 per share, down 4% from the US$130 million or US$0.33 per share it posted during 3Q 2018.

The figures beat Wall Street expectations of US$0.28 per share and revenue of US$1.44 billion.

CEO Chip Bergh told shareholders that the company delivered strong third-quarter results and remains on-track to achieve its full-year expectations.

“Our strategies to diversify to faster-growing, high-opportunity, high gross margin businesses continue to drive momentum, as we again grew revenues double-digits internationally, in our direct-to-consumer business, and in the women’s and tops categories,” Bergh said in a statement.

Bergh said that the company expects “strong performance” in the fourth quarter in international, direct-to-consumer, women's and tops, and improved comparisons for US wholesale.

“We'll stay focused on what we can control as we grow this business over the long-term.”

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Levi Strauss & Co

Price: 20.22 USD

NYSE:LEVI
Market: NYSE
Market Cap: $7.97 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Genprex sees newly licensed diabetes gene therapy as an...

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive the Texas-based biotech has signed a licensing agreement with the University of Pittsburgh for a diabetes gene therapy that could have the potential to treat Type 1 and Type 2 diabetes. Varner says the newly licensed diabetes gene...

2 days, 12 hours ago

2 min read